drugset / Trial / NCT00004928
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
Treatment
Summary
RATIONALE: Calcitriol may help prostate cancer cells develop into normal cells. Zoledronate may delay or prevent the formation of bone metastases. Combining calcitriol and zoledronate may be an effective treatment for progressive prostate cancer. PURPOSE: Phase I trial to study the effectiveness of combining calcitriol with zoledronate in treating patients who have progressive prostate cancer.
Timeline
- Start
- 1999-10
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | — | Oral |
| Subject | Zoledronic acid | Other / unclassified | — | Intravenous |